<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-720
Date of Submission: 2025-01-07

This report was submitted by a Patient from Young, Wilson and Dickerson Medical Center concerning patient ANON-PX-3730. The subject is a 49-year-old female with a significant medical history including osteoarthritis, hypertension, atrial fibrillation. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Omeprazole (Proton-pump inhibitor) administered via the Intramuscular route at a dosage of 257mg, initiated on 2024-11-01 for Gastroesophageal reflux disease with the course ongoing; Gabapentin administered via the Intramuscular route at a dosage of 333mg, initiated on 2024-11-01 for Neuropathic pain with the course ongoing.

On approximately 2024-12-05, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Somnolence, Maculopapular Rash. The Somnolence was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. The Maculopapular Rash was classified as Mild in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 5 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Cup visit machine power bed move baby skill. Matter throughout industry.</data>
report_id: ADR-2025-720
report_date: '2025-01-07'
patient_details:
  patient_id: ANON-PX-3730
  gender: Female
  relevant_history:
  - osteoarthritis
  - hypertension
  - atrial fibrillation
  age_at_reaction: 49
suspected_drugs:
- drug_name: Omeprazole
  dosage: 257mg
  route_of_administration: Intramuscular
  start_date: '2024-11-01'
  indication_for_use: Gastroesophageal reflux disease
  drug_class: Proton-pump inhibitor
- drug_name: Gabapentin
  dosage: 333mg
  route_of_administration: Intramuscular
  start_date: '2024-11-01'
  indication_for_use: Neuropathic pain
adverse_reactions:
- symptom_name: Somnolence
  onset_date: '2024-12-05'
  severity: Moderate
  outcome: Recovered
  intervention_required: false
- symptom_name: Maculopapular Rash
  onset_date: '2024-12-05'
  severity: Mild
  outcome: Not Recovered
  intervention_required: true
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Not applicable
  naranjo_score: 5
reporting_facility: Young, Wilson and Dickerson Medical Center
reporter_type: Patient
notes: Cup visit machine power bed move baby skill. Matter throughout industry.
